NuStar GP Holdings, LLC (NYSE:NSH) Director James F. Clingman sold 5,550 shares of the company’s stock in a transaction dated Wednesday, September 28th. The shares were sold at an average price of $25.35, for a total transaction of $140,692.50. Following the completion of the sale, the director now directly owns 40,947 shares in the company, valued at $1,038,006.45. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
NuStar GP Holdings, LLC (NYSE:NSH) opened at 25.58 on Monday. The company has a 50-day moving average of $24.75 and a 200-day moving average of $24.14. The firm has a market cap of $1.10 billion, a price-to-earnings ratio of 17.85 and a beta of 1.02. NuStar GP Holdings, LLC has a 52 week low of $12.86 and a 52 week high of $31.55.
NuStar GP Holdings (NYSE:NSH) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by $0.01. Equities research analysts forecast that NuStar GP Holdings, LLC will post $1.48 earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Brown Advisory Securities LLC acquired a new position in shares of NuStar GP Holdings during the second quarter worth about $254,000. Kayne Anderson Capital Advisors LP purchased a new position in NuStar GP Holdings during the second quarter worth $2,822,000. GSA Capital Partners LLP raised its position in NuStar GP Holdings by 12.9% in the second quarter. GSA Capital Partners LLP now owns 42,683 shares of the company’s stock worth $1,094,000 after buying an additional 4,878 shares during the last quarter. BB&T Securities LLC purchased a new position in NuStar GP Holdings during the second quarter worth $274,000. Finally, M&T Bank Corp purchased a new position in NuStar GP Holdings during the second quarter worth $213,000.
NSH has been the topic of a number of research analyst reports. Mizuho initiated coverage on shares of NuStar GP Holdings in a report on Thursday. They issued a “neutral” rating and a $26.00 target price on the stock. Zacks Investment Research cut shares of NuStar GP Holdings from a “hold” rating to a “sell” rating in a report on Friday, August 5th. Citigroup Inc. raised shares of NuStar GP Holdings from a “neutral” rating to a “buy” rating and upped their target price for the company from $26.00 to $29.00 in a report on Friday, August 12th. US Capital Advisors reaffirmed a “hold” rating on shares of NuStar GP Holdings in a report on Wednesday, September 21st. Finally, TheStreet cut shares of NuStar GP Holdings from a “hold” rating to a “sell” rating in a report on Friday, September 2nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company. NuStar GP Holdings has an average rating of “Hold” and an average target price of $27.33.
About NuStar GP Holdings
NuStar GP Holdings, LLC holds interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the transportation of petroleum products and anhydrous ammonia, the terminalling and storage of petroleum products, and the marketing of petroleum products. NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St.
Receive News & Ratings for NuStar GP Holdings LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NuStar GP Holdings LLC and related companies with MarketBeat.com's FREE daily email newsletter.